Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Epilepsy × Radiotherapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 156 Breast Neoplasms 142 Prostatic Neoplasms 127 Lung Neoplasms 124 Glioblastoma 112 Head and Neck Neoplasms 106 Rectal Neoplasms 97 Lymphoma 96 Squamous Cell Carcinoma of Head and Neck 94 Esophageal Neoplasms 91 Pancreatic Neoplasms 70 Leukemia 65 Esophageal Squamous Cell Carcinoma 64 Neoplasms 60 Brain Neoplasms 60 Precursor Cell Lymphoblastic Leukemia-Lymphoma 57 Lymphoma, Non-Hodgkin 57 Lymphoma, Follicular 57 Lymphoma, Large B-Cell, Diffuse 52 Hodgkin Disease 52 Central Nervous System Neoplasms 50 Leukemia, Lymphocytic, Chronic, B-Cell 48 Gliosarcoma 47 Uterine Cervical Neoplasms 45 Sarcoma 45 Colorectal Neoplasms 44 Lymphoma, Large-Cell, Immunoblastic 41 Glioma 41 Burkitt Lymphoma 41 Lymphoma, Mantle-Cell 39

Interventions

Sirolimus 4 Everolimus 3 Anticonvulsants 2 ziprasidone 1 perampanel 1 enzalutamide 1 clevidipine 1 brivaracetam 1 Zolpidem 1 Warfarin 1 Vigabatrin 1 Vecuronium Bromide 1 Vancomycin 1 Tranexamic Acid 1 Tobramycin 1 Therapeutic Touch 1 Temozolomide 1 Surgical Procedures, Operative 1 Sulfasalazine 1 Spironolactone 1 Sevoflurane 1 Sevelamer 1 Saline Solution 1 Rocuronium 1 Registries 1 Radiotherapy 1 Propofol 1 Piperacillin, Tazobactam Drug Combination 1 Pentobarbital 1 Oxycodone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05664464 2024-05-10

GLUGLIO

University of Zurich

Phase 1/2 Recruiting

Epilepsy, Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡